Lloyd J. Old

Memorial Sloan Kettering Cancer Center — United States

Immunology and Microbiology · Life Sciences

155h-index111.9kcitations961works0.02yr avg

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Immunotherapy and Immune Responses(433), Monoclonal and Polyclonal Antibodies Research(296), Glycosylation and Glycoproteins Research(171), T-cell and B-cell Immunology(118), vaccines and immunoinformatics approaches(116)

Publications958 total

Data from Nonclassical Antigen-Processing Pathways Are Required for MHC Class II–Restricted Direct Tumor Recognition by NY-ESO-1–Specific CD4+ T Cells

2023Open Access

Supplementary Figure 1 from Nonclassical Antigen-Processing Pathways Are Required for MHC Class II–Restricted Direct Tumor Recognition by NY-ESO-1–Specific CD4+ T Cells

2023Open Access

Supplementary Figure 2 from Nonclassical Antigen-Processing Pathways Are Required for MHC Class II–Restricted Direct Tumor Recognition by NY-ESO-1–Specific CD4+ T Cells

2023Open Access

Supplementary Figure 1 from Nonclassical Antigen-Processing Pathways Are Required for MHC Class II–Restricted Direct Tumor Recognition by NY-ESO-1–Specific CD4+ T Cells

2023Open Access

Data from Nonclassical Antigen-Processing Pathways Are Required for MHC Class II–Restricted Direct Tumor Recognition by NY-ESO-1–Specific CD4+ T Cells

2023Open Access

Supplementary Figure 3 from Nonclassical Antigen-Processing Pathways Are Required for MHC Class II–Restricted Direct Tumor Recognition by NY-ESO-1–Specific CD4+ T Cells

2023Open Access

Supplementary Figure 3 from Nonclassical Antigen-Processing Pathways Are Required for MHC Class II–Restricted Direct Tumor Recognition by NY-ESO-1–Specific CD4+ T Cells

2023Open Access

Supplementary Figure 2 from Nonclassical Antigen-Processing Pathways Are Required for MHC Class II–Restricted Direct Tumor Recognition by NY-ESO-1–Specific CD4+ T Cells

2023Open Access

Data from Efficient In vivo Priming by Vaccination with Recombinant NY-ESO-1 Protein and CpG in Antigen Naïve Prostate Cancer Patients

2023Open Access

Supplementary Table 3 from Cancer-Testis Antigens: Expression and Correlation with Survival in Human Urothelial Carcinoma

2023Open Access

Supplementary Table 3 from Cancer-Testis Genes Are Coordinately Expressed and Are Markers of Poor Outcome in Non–Small Cell Lung Cancer

2023Open Access

Supplementary Figure 3 from Prostate Cancer Progression Correlates with Increased Humoral Immune Response to a Human Endogenous Retrovirus GAG Protein

2023Open Access

Supplementary Figure 1 from Phase I Clinical Trial of Mixed Bacterial Vaccine (Coley's Toxins) in Patients with NY-ESO-1 Expressing Cancers: Immunological Effects and Clinical Activity

2023Open Access

Supplementary Table 1 from Cancer-Testis Antigens: Expression and Correlation with Survival in Human Urothelial Carcinoma

2023Open Access

Data from Two Distinct Mechanisms of Augmented Antitumor Activity by Modulation of Immunostimulatory/Inhibitory Signals

2023Open Access

Supplementary Figure 3 from Phase I Clinical Trial of Mixed Bacterial Vaccine (Coley's Toxins) in Patients with NY-ESO-1 Expressing Cancers: Immunological Effects and Clinical Activity

2023Open Access

Data from Efficient In vivo Priming by Vaccination with Recombinant NY-ESO-1 Protein and CpG in Antigen Naïve Prostate Cancer Patients

2023Open Access

Data from MAGE-A Inhibits Apoptosis in Proliferating Myeloma Cells through Repression of Bax and Maintenance of Survivin

2023Open Access

Supplementary Table 1 from Cancer-Testis Antigens: Expression and Correlation with Survival in Human Urothelial Carcinoma

2023Open Access

Supplementary Table 2 from Cancer-Testis Genes Are Coordinately Expressed and Are Markers of Poor Outcome in Non–Small Cell Lung Cancer

2023Open Access

page 1 of 48Next →

Frequent Co-authors

Robert D. Schreiber(10), Achim A. Jungbluth(9), Sacha Gnjatic(8), Yao‐Tseng Chen(8), Gerd Ritter(6), Elisabeth Stockert(6), Barbara Williamson(5), Matthew J. Scanlan(5), Elke Jäger(5), Alexander Knuth(5), Wolfgang J. Rettig(4), Julia Karbach(4), Michael Arand(4), Edward A. Boyse(4), Mark J. Smyth(3), Gavin P. Dunn(3), Hiroaki Ikeda(3), E A Carswell(3), Andrew M. Scott(3), Andrew J.G. Simpson(3)